1 year return (CAGR)
251.60%
Oruka Therapeutics, Inc. Exchange (NASDAQ, USD)
ORKA
95.81
+5.48 (+6.07%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
57.85%
5 year return (CAGR)
23.85%
10 year return (CAGR)
-15.95%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
6.34B
Price/Sales
-
Ent value
6.10B
Price/Book
5.69
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
2.26%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 89.02 |
| Daily high | 96.59 |
| Daily low | 89.02 |
| Daily Volume | 1.21M |
| All-time high | 1000024.70 |
| 1y analyst estimate | 155.00 |
| Beta | -0.21 |
| EPS (TTM) | -2.11 |
| Dividend per share | 0.00 |
| Ex-div date | 29 Aug 2024 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ORKA | S&P500 | |
| Current price drop from All-time high | -99.99% | -1.21% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 10 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -66.30% | -10.65% |
| Avg time to new high | 5 days | 12 days |
| Max time to new high | 7349 days | 1805 days |
News
